Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials

Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers – A pharmacoepidemiological cross-sectional multicenter study

(2016) Markus Dold et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Evidence-based pharmacotherapy of treatment-resistant unipolar depression

(2016) Markus Dold et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE

Antidepressants Accumulate in Lipid Rafts Independent of Monoamine Transporters to Modulate Redistribution of the G Protein, Gαs

(2016) Samuel J. Erb et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature

(2016) André F. Carvalho et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression

(2015) F Hieronymus et al.   MOLECULAR PSYCHIATRY

Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review

(2015) Giovanni A. Fava et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Rational Use of Antidepressant Drugs

(2014) Giovanni A. Fava   PSYCHOTHERAPY AND PSYCHOSOMATICS

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

(2013) Michael Bauer et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

(2011) C. Hiemke et al.   PHARMACOPSYCHIATRY

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

(2009) Andrea Cipriani et al.   LANCET

Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy

(2008) Henricus G Ruhé et al.   NEUROPSYCHOPHARMACOLOGY

Safety of High-intensity Treatment with the Irreversible Monoamine Oxidase Inhibitor Tranylcypromine in Patients with Treatment-resistant Depression

(2008) M. Adli et al.   PHARMACOPSYCHIATRY